|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||345.90 - 349.85|
|52 Week Range||290.55 - 349.85|
|Beta (5Y Monthly)||0.27|
|PE Ratio (TTM)||21.07|
|Earnings Date||Jul 22, 2021|
|Forward Dividend & Yield||9.10 (2.62%)|
|Ex-Dividend Date||Mar 18, 2021|
|1y Target Est||259.86|
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Nucleic acid test for use on the cobas® Liat® System. This singleplex test is the first real-time reverse transcriptase polymerase chain reaction (RT-PCR) test that can identify SARS-CoV-2 infection within 20 minutes.
In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment of Alzheimer’s.
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss progress in the fight against COVID-19.